£365k
−79%vs Jun 2024Active12392992Private limited companyLondon
GENOME THERAPEUTICS LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Genome Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Genome Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
GENOME THERAPEUTICS LTD is an active private limited company (company number 12392992) incorporated on 8 January 2020, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of £365k and cash of £363k, with 6 employees on average. Net assets fell 79% on the prior period (£1.71m).
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
No active person with significant control is registered.
- Dr Bobby Satyadev Yerramilli-Rao
- owns 25–50% of shares
- holds 25–50% of voting rights
- Prof Sir Shankar Balasubramanian
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Samuel Aparicio
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr Samuel Aparicio
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 8 January 20206 yrs ago
- Next accounts due
- 30 March 2027in 152 days
- Confirmation statement due
- 22 January 2027in 85 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
05
Financials
£363k
−75%vs Jun 2024Not reported
6
No changevs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £365k | £363k | £214k | — | — | — | 6 |
| 30 June 2024 | £1.71m | £1.47m | £471k | — | — | — | 6 |
Cash per employee£60kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £364,835 at 30 June 2025
- Net assets down 25% or more on the prior period-78.6% vs prior period
- Cash at bank of £50,000 or moreCash £362,941
- Incorporated five or more years agoIncorporated 8 January 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 152 days
- Confirmation statement duein 85 days
- Accounts period endNet assets £365k · small accounts
- Accounts period endNet assets £1.71m · small accounts
- Incorporated
08
Similar companies in London
- BETTER DAIRY LIMITEDLondon · inc. Jan 2020
- NEURITEK THERAPEUTICS LTDLondon · inc. Jan 2020
- SUTURA THERAPEUTICS LIMITEDLondon · inc. Jan 2020
- BIO-RECELL LTDLondon · inc. Jan 2020
- OXFORD STEMTECH LTDLondon · inc. Jan 2020
- AVIADOBIO LTDLondon · inc. Dec 2019
All companies incorporated on 8 January 2020 · in Jan 2020.
09
Reminders for GENOME THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.